Blood Transfusion Diagnostics Market (By Product: Reagents & Kits, Instruments, and Others; By Application: Blood Grouping and Disease Screening; By End-use: Hospitals, Blood Banks, Diagnostic Laboratories, and Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2021-2028

CHAPTER 1. Industry Overview of Blood Transfusion Diagnostics

1.1. Definition and Scope 

1.1.1. Definition of Blood Transfusion Diagnostics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Blood Transfusion Diagnostics market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Blood Transfusion Diagnostics By Product

1.2.3. Blood Transfusion Diagnostics By Application

1.2.4. Blood Transfusion Diagnostics By End-Use

1.2.5. Blood Transfusion Diagnostics by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Blood Transfusion Diagnostics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Blood Transfusion Diagnostics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Blood Transfusion Diagnostics Major Manufacturers in 2019

CHAPTER 5. Blood Transfusion Diagnostics By Product

5.1. Introduction

5.2. Blood Transfusion Diagnostics Revenue By Product

5.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast, By Product, 2017-2028

5.2.2. Reagents & Kits

5.2.2.1. Reagents & Kits Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.3. Instruments

5.2.3.1. Instruments  Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.4. Others

5.2.4.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 6. Blood Transfusion Diagnostics Market Revenue By Application

6.1. Introduction

6.2. Blood Transfusion Diagnostics Revenue (US$ Bn) By Application

6.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

6.2.2. Blood Grouping

6.2.2.1. Blood Grouping Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3. Disease Screening

6.2.3.1. Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3.1.1. Serological Disease Screening

6.2.3.1.1.1. Serological Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3.1.2. Molecular Disease Screening

6.2.3.1.2.1. Molecular Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 7. Blood Transfusion Diagnostics Market By End-use 

7.1. Introduction

7.2. Blood Transfusion Diagnostics Revenue (US$ Bn) By Product

7.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.3. Blood Banks

7.2.3.1. Blood Banks Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.4. Diagnostic Laboratories

7.2.4.1. Diagnostic Laboratories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.5. Others

7.2.5.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 8. North America Blood Transfusion Diagnostics Market By Country 

8.1. North America Blood Transfusion Diagnostics Overview

8.2. U.S.

8.2.1. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

8.2.2. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

8.2.3. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

8.3. Canada

8.3.1. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

8.3.2. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

8.3.3. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

8.4. North America PEST Analysis

CHAPTER 9. Europe Blood Transfusion Diagnostics Market By Country

9.1. Europe Blood Transfusion Diagnostics Overview

9.2. U.K.

9.2.1. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.2.2. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

9.2.3. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

9.3. Germany

9.3.1. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.3.2. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

9.3.3. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

9.4. France 

9.4.1. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.4.2. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

9.4.3. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

9.5. Spain

9.5.1. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.5.2. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

9.5.3. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

9.6. Rest of Europe

9.6.1. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.6.2. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

9.6.3. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Blood Transfusion Diagnostics Market By Country

10.1. Asia Pacific Blood Transfusion Diagnostics Overview

10.2. China

10.2.1. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.2.2. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.2.3. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.3. Japan

10.3.1. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.3.2. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.3.3. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.4. India

10.4.1. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.4.2. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.4.3. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.5. Australia

10.5.1. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.5.2. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.5.3. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.6. South Korea

10.6.1. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.6.2. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.6.3. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.7.2. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.7.3. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Blood Transfusion Diagnostics Market By Country

11.1. Latin America Blood Transfusion Diagnostics Overview

11.2. Brazil

11.2.1. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.2.2. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.2.3. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

11.3. Mexico

11.3.1. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.3.2. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.3.3. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

11.4. Rest of Latin America

11.4.1. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.4.2. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.4.3. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Blood Transfusion Diagnostics Market By Country 

12.1. Middle East & Africa Blood Transfusion Diagnostics Overview

12.2. GCC

12.2.1. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.2.2. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.2.3. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

12.3. South Africa

12.3.1. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.3.2. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.3.3. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.4.2. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.4.3. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Blood Transfusion Diagnostics

13.1. Blood Transfusion Diagnostics Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Blood Transfusion Diagnostics market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE

14.1. Abbott Laboratories 

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (US$ Bn), 2020

14.1.3.2. Abbott Laboratories 2020 Blood Transfusion Diagnostics Business Regional Distribution

14.1.4. Product/ Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. BAG Healthcare GmbH

14.3. Immucor Inc.

14.4. Danaher

14.5. Ortho Clinical Diagnostics

14.6. Bio-Rad Laboratories

14.7. F. Hoffmann-La Roche AG

14.8. Quotient Limited

14.9. DiaSorin S.P.A.

14.10. BIOKIT (Werfen)